AAV-mediated DMPK silencing: A defining moment in myotonic dystrophy type 1 therapeutics is a research paper published in Molecular Therapy (2025). On theSindex it has a DataRank of 0.165. It has been cited 2 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.165
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Muscular Dystrophy Canada
Grant: 855673
Canadian Institutes of Health Research
Grant: MOP-111072
Canadian Institutes of Health Research
Grant: MOP-130373
Canadian Institutes of Health Research
Grant: unidentified
unidentified
Institute of Circulatory and Respiratory Health
U.S. Army Medical Research Acquisition Activity
US Department of Defense
FWCI
0.94
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords